Pfizer's Tilrekimig Posts Phase II Skin Clearance, Sets Up Dupilumab Head-to-Head
Pfizer's tilrekimig produced Phase II skin clearance in atopic dermatitis and is positioned for a direct head-to-head against dupilumab, the IL-4/IL-13 incumbent that defines the moderate-to-severe e…